CA
NZ
UK
AU
IND
US
Glioblastoma remains among the most treatment-resistant cancers known to medicine. Median survival after diagnosis hovers around 15 months, and the therapeutic landscape has seen little meaningful innovation in over two decades. Against this backdrop, BioLineRx (Nasdaq:BLRX) and its partner Hemispherian AS announced on April …
In clinical-stage biotechnology, a single adverse event can reset years of accumulated investor confidence within hours. For Erasca (Nasdaq: ERAS), two successive sessions delivered compounding shocks: aPatentdispute on April 27 and a treatment-linked fatality disclosed on April 28, sending shares down 48.30% to close …
NeuroSense Therapeutics (Nasdaq:NRSN) surged 7.78% after announcing a USD 600,000 insider-led PIPE financing, with the CEO and CFO each committing USD 200,000 at a premium toMarket Priceahead of key clinical and regulatory milestones.Key HighlightsNeuroSense Therapeutics closed up 7.78% at USD 0.81 on April 28, …
Teradyne, Inc. (Nasdaq: TER) reported first-quarter 2026Revenueof USD 1.282 billion, representing an 87% increase from USD 686 million in the prior-year period. The performance exceeded the company’s guidance range and reflects a sharp acceleration inDemandfor semiconductor testing equipment linked to artificial intelligence infrastructure.
Fair Isaac Corporation (NYSE: FICO) reported second-quarter FY2026Revenueof USD 692 million, representing a 39% year-on-year increase. The primary driver was the Scores segment, which generated USD 475 million inRevenue, up 60% YoY.
Ingersoll Rand (NYSE: IR) delivered first-quarterRevenueof USD 1.85 billion, up 8% year-on-year, with growth largely supported by acquisitions and favourable currency movements rather than underlyingDemandstrength.
ONEOK (NYSE: OKE) delivered a solid first-quarter performance, withNet Incomerising to USD 776 million and adjusted EBITDA reaching approximately USD 2.0 billion. The improvement reflects continued expansion in volumes across its integratedMidstreamnetwork, particularly inNatural Gasliquids (NGLs), refined products, andNatural Gastransportation.
Sysco Corporation (NYSE: SYY) deliveredRevenueof USD 20.5 billion in Q3 FY2026, representing a 4.7% increase compared with the same period last year. Growth was supported by bothVolumeexpansion and favorable pricing dynamics.
index/">indexUpdateU.S. equities closed on a mixed note on Tuesday, with the S&P 500 declining 0.4% and theNasdaq/">Nasdaqfalling 1%, weighed down by weakness in AI-linked stocks and rising oil prices. Investor sentiment was impacted by reports indicating slower-than-expected growth at OpenAI, which pressured semiconductor stocks …
Trend Structure: Uptrend Intact but CoolingGLW remains in a broader bullish structure, though momentum has softened recently.Key observations include:• Clear pattern of higher highs and higher lows over time• Strong rally followed by a corrective pullback• Price holding above medium-term support levelsThis suggests:• Buyers …
Please wait processing your request...